Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 141

1.

[Male hypogonadism - recommendations for diagnosis and therapy].

Heufelder AE, Wetterauer U, Yassin A.

MMW Fortschr Med. 2014 Nov 6;156(19):57-9. Review. German. No abstract available.

PMID:
25510026
2.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators.

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

3.
4.

Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy.

Dickinson AJ, Vaidya B, Miller M, Coulthard A, Perros P, Baister E, Andrews CD, Hesse L, Heverhagen JT, Heufelder AE, Kendall-Taylor P.

J Clin Endocrinol Metab. 2004 Dec;89(12):5910-5.

PMID:
15579735
5.

[New therapeutic options in obesity].

Heufelder AE.

MMW Fortschr Med. 2003 Oct 16;145(42):35-9. Review. German.

PMID:
14655442
6.

Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.

Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE, Halkias A.

Eur J Endocrinol. 2003 May;148(5):491-5.

7.

Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.

Schipper ML, Weber A, Béhé M, Göke R, Joba W, Schmidt H, Bert T, Simon B, Arnold R, Heufelder AE, Behr TM.

Cancer Res. 2003 Mar 15;63(6):1333-8.

8.

Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.

Hofbauer LC, Kluger S, Kühne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE.

J Cell Biochem. 2002;86(4):642-50.

PMID:
12210731
10.

Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Heufelder AE.

Rev Endocr Metab Disord. 2000 Jan;1(1-2):87-95. Review.

PMID:
11704996
11.
12.

Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.

Heufelder AE, Morgenthaler N, Schipper ML, Joba W.

Thyroid. 2001 Sep;11(9):839-47. Review.

PMID:
11575853
13.

Autoimmunity involving the human sodium/iodide symporter: fact or fiction?

Heufelder AE, Joba W, Morgenthaler NG.

Exp Clin Endocrinol Diabetes. 2001;109(1):35-40. Review.

PMID:
11573137
14.
15.

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.

Hofbauer LC, Heufelder AE.

J Mol Med (Berl). 2001 Jun;79(5-6):243-53. Review.

PMID:
11485016
16.

Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.

Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD.

J Clin Endocrinol Metab. 2001 Jul;86(7):3162-5.

PMID:
11443182
17.

Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.

Hofbauer LC, Heufelder AE, Erben RG.

J Rheumatol. 2001 Apr;28(4):685-7. Review. No abstract available.

18.

Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts.

Krassas GE, Heufelder AE.

Eur J Endocrinol. 2001 Apr;144(4):311-8. Review.

19.

[Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].

Hofbauer LC, Heufelder AE.

Dtsch Med Wochenschr. 2001 Feb 9;126(6):145-50. Review. German. No abstract available.

PMID:
11233883
20.

Expression of the sodium iodide symporter in human kidney.

Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC.

Kidney Int. 2001 Mar;59(3):1013-23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk